RituxiMab INDuction in Renal Transplantation

Sponsor
Guy's and St Thomas' NHS Foundation Trust
Study ID
NCT01095172
Phase
PHASE4
Status
Unknown

Conditions

  • Function of Renal Transplant

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Rituximab — DRUG
    375mg/m\^2, single dose given 2-4 weeks prior to transplantation
  • Tacrolimus — DRUG
    dose calculated to give levels of 3-7ng/ml
  • Mycophenylate mofetil — DRUG
    Mycophenylate mofetil 2g/day in divided doses
  • Hydrocortisone — DRUG
    100mg hydrocortisone on the evening of the day of surgery and 2 further doses of hydrocortisone on day 1 post transplant.
  • Prednisolone — DRUG
    Prednisolone 0.3mg/kg on day 2, 0.25mg/kg on day 3, 0.2mg/kg on day 4 and 0.16mg/kg on day 5. On day 6 they will receive 5mg prednisolone, and on day 7 none.
  • Prednisolone — DRUG
    Reducing dose of prednisolone over at least 6 months. Subsequent steroid maintenance or withdrawal will be at the discretion of the patient's clinician.

Study Details

Hypothesis: * That B cell depletion, rather than reducing acute rejection, will allow minimisation of immunosuppression, which may lead to better graft survival. Aim: * To assess whether the addition of rituximab to a low-dose tacrolimus immunosuppression regime allows a reduction in steroid administration. Objectives: * To assess whether B cell depletion affects graft function, acute rejection and complication rates * To assess whether the T cell response to allotransplantation is impaired by B cell depletion.

Key Dates

Start date
Nov 30, 2010
Status verified
Jul 2020
Primary completion
Oct 31, 2020
Completion
Oct 31, 2022

Study Design

Enrollment
100 participants (actual)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: Rituximab
    Rituximab 375mg/m2 Low dose tacrolimus with mycophenylate mofetil, hydrocortisone and 1 week prednisolone
  • Active Comparator: Control group
    Low dose tacrolimus with mycophenylate mofetil and continued prednisolone

Primary Outcome Measure

Estimated GFR (calculated using the Cockcroft-Gault formula) [ Time Frame: 1 year ]